SCHEMBL9683245

SCHEMBL9683245

c1ccc(-c2nc3cc4ccccc4cc3o2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.62
RAB9A P51151 8/20 0.62
SMN1; SMN2 Q16637 7/20 0.62
KDM4E B2RXH2 5/20 0.62
HPGD P15428 4/20 0.62
CASP3 P42574 3/20 0.62
SENP7 Q9BQF6 3/20 0.62
SENP6 Q9GZR1 3/20 0.62
POLB P06746 2/20 0.62
SENP8 Q96LD8 2/20 0.62
ALDH1A1 P00352 5/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 4/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
HDAC6 Q9UBN7 1/20 0.51
TP53 P04637 2/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26745313 0.92 SMN1; SMN2 (0.67) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL26745185 0.91 NPC1 (0.60) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL25796564 0.90 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL9018554 0.90 NPC1 (0.68) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL21674252 0.90 NPC1 (0.51) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL15413714 0.88 NPC1 (0.66) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL21674153 0.87 NPC1 (0.50) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL903716 0.86 NPC1 (0.64) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL21674303 0.86 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2KDM4EHPGD
SCHEMBL30545869 0.86 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-30 US disclosed
EP-4019503-A2 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-29 EP disclosed
EP-0479161-A1 Synthesis of heterocyclic compounds EASTMAN CHEMICAL COMPANY (US) 1992-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME EML4, STOM, GJB2 NPC1 3939/4885RAB9A 1754/4885SMN1; SMN2 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.